HEATHER NELSON: Open Payments
NPI 1811733314 · VINELAND, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$744 in 39 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $99 · 2025 $744
Food & beverage: $744
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $148 |
| Amgen Inc. | 5 | $92 |
| Lilly USA, LLC | 5 | $85 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| Novo Nordisk Inc | 2 | $38 |
| ABBVIE INC. | 2 | $33 |
| Exact Sciences Corporation | 1 | $32 |
Products named: Kerendia, LEQVIO, REXULTI, MOUNJARO, AIRSUPRA, XIFAXAN, Ozempic, REPATHA.
Industry payments across NJ — which companies pay providers there.
